About Cytokine receptor common subunit gamma
Cytokine receptor common subunit gamma (IL2RG) is a protein
from Homo sapiens identified by UniProt accession
P31785, 369 residues long.
MolForge cross-references it against 0 known binders and
543 disease associations.
Target properties
| Protein name | Cytokine receptor common subunit gamma |
| UniProt accession | P31785 |
| Gene | IL2RG |
| Organism | Homo sapiens |
| Length | 369 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (543)
Diseases linked to this target (Open Targets).
- gamma chain deficiency · score 0.84
- X-Linked Combined Immunodeficiency Diseases · score 0.72
- Omenn syndrome · score 0.56
- severe combined immunodeficiency · score 0.47
- T-B+ severe combined immunodeficiency · score 0.46
- genetic disorder · score 0.44
- breast adenocarcinoma · score 0.29
- neurodegenerative disease · score 0.28
- endometrial cancer · score 0.27
- lung adenocarcinoma · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P31785-F1 | alphafold | PREDICTED | 75.52 | — |
Amino-acid sequence (369 residues)
MLKPSLPFTS LLFLQLPLLG VGLNTTILTP NGNEDTTADF FLTTMPTDSL SVSTLPLPEV QCFVFNVEYM NCTWNSSSEP QPTNLTLHYW YKNSDNDKVQ KCSHYLFSEE ITSGCQLQKK EIHLYQTFVV QLQDPREPRR QATQMLKLQN LVIPWAPENL TLHKLSESQL ELNWNNRFLN HCLEHLVQYR TDWDHSWTEQ SVDYRHKFSL PSVDGQKRYT FRVRSRFNPL CGSAQHWSEW SHPIHWGSNT SKENPFLFAL EAVVISVGSM GLIISLLCVY FWLERTMPRI PTLKNLEDLV TEYHGNFSAW SGVSKGLAES LQPDYSERLC LVSEIPPKGG ALGEGPGASP CNQHSPYWAP PCYTLKPET
Explore Cytokine receptor common subunit gamma with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets